Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Healthy

Interventions

DRUG

BI 1060469

single rising doses given as tablet

DRUG

Placebo

given as tablet (matching placebo of BI 1060469)

Trial Locations (2)

1333.3.82002 Boehringer Ingelheim Investigational Site, Busan

1333.3.82001 Boehringer Ingelheim Investigational Site, Seoul